SalemH.AviadoD.M.: Antitussive drugs with special reference to a new theory for the initiation of the cough reflex and the influence of bronchodilators, Am. J. Med. Sci.247: 585–600, 1964.
2.
GreeneL.C.: Techniques for evaluating antitussive drugs in animals, pp. 312–321. In: MantegezzaP.PiccininiF., eds., Methods in drug evaluation. North Holland Publishing Co., Amsterdam, 1966.
3.
TersteegeH.M.FunckeA.B.H.LouwerseW.J.NautaW. Th.: Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2, 6-xylylmethoxyethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent. Arch. Int. Pharmacodyn. Ther.161: 314–333, 1966.
BickermanH.A.RodgersJ.M.ReillyE.B.: Role of bronchoconstriction in the cough reflex, Clin. Pharmacol. Ther.14: 131, 1973.
6.
BucherK.: Tessalon, ein hustenstillendes Mittel von neuartigem Wirkungsmechanismus, Schweiz. Med. Wochenschr.86: 94–96, 1956.
7.
SalemH.AviadoD.M.: Antitussive agents, pp.1–833. In: International Encyclopedia of Pharmacology and Therapeutics, section 27, Vols. 1, 2 and 3. Pergamon Press, London, 1970.
8.
SilvestriniB.MaffiiG.: Rilevo dell'azione antitosse negli animali di laboratorio e rapporti tra azione bechica ed altre proprieta farmacologiche, Farmaco Sci.14: 440–464, 1959.
9.
WinterC.A.FlatakerL.: Antitussive compounds: Testing methods and results, J. Pharmacol. Exp. Ther.112: 99–108, 1954.
10.
KallqvistI.MelanderB.: Experimental and clinical evaluation of chlorcyclizine as an antitussive, Arzneim. Forsch.7: 301–304, 1957.
11.
SalleJ.BrunaudM.: Nouvelle technique d'enregistrement des mouvements de toux provoques par l'inhalation de vapeurs irritantes chez le cobaye, Arch. Int. Pharmacodyn. Ther.126: 120–125, 1960.
12.
WinterC.A.FlatakerL.: The effects of drugs upon a graded cough response obtained in sensitized guinea pigs exposed to aerosol of specific antigen, J. Exp. Med.101: 17–24, 1955.
13.
PeacockP.R.: Cough reflex in animals, Br. Med. J.1:120. 1964.
14.
SalemH.AviadoD.M.: Previously unpublished data presented in Tables 3–6 of this paper.
15.
EichlerO.SmiatekA.: Versuche zur Auswertung von Mitteln zur Bekaempfung des Reizhustens, Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol.194: 621–628, 1940.
16.
OgataA.TakagiK.MizutaniA.: Apparatus for the assay of compounds possessing activities against central nerves to stop coughing, J. Pharm. Soc. Jap.63: 412–416, 1943.
17.
FriebelH.ReichleC.GraevenitzA.V.: Zur Hemmung des Hustenreflexes durch zentral angreifende Arzneimittel, Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol.224: 384–400, 1955.
18.
TakagiK.FukudaH.YanoK.: Studies on antitussives I. Bioassay of antitussives, J. Pharm. Soc. Jap.80: 1497–1501, 1960.
19.
HaraS.YanauraS.: A method of inducing and recording cough and examination of the action of some drugs with this method, Jap. J. Pharmacol.9: 46–54, 1959.
20.
ChermatR.KornowskiH.JondetA.: Technique de selection rapide des substances antitussives; application a l'evaluation de l'activite d'un derive de la promethazine, Ann. Pharm. Fr.24: 181–184, 1966.
21.
LemeignanM.StreichenbergerG.LechatP.: The use of decerebrated guinea pigs for the study of antitussive agents, Therapie21: 361–366, 1966.
22.
TomoriZ.GombosB.BenickyL.MokranovaL.LuptakovaM.: Acetylcholine test in patients working in dusty atmospheres and in cats, pp.221–225. In: AviadoD.M.PalecekF., eds., vol. 11, Drugs and respiration, Proc. 2nd Int. Pharmacol Meet. Pergamon Press, London, 1964.
23.
StefkoP.L.DenzelJ.HickeyI.: Experimental investigation of nine antitussive drugs, J. Pharm. Sci.50: 216–221, 1961.
24.
MullerB.: Zum Mechanismus des Hustens, Helv. Physiol. Pharmacol. Acta12: 137–146, 1954.
25.
GutekunstJ.A.: Zur Charakterisierung der Hustenstaerke durch den Pleuradruck, Helv. Physiol. Pharmacol. Acta13: 295–299, 1955.
26.
MayA.J.WiddicombeJ.C.: Depression of the cough reflex by pentobarbitone and some opium derivatives, Br. J. Pharmacol.9: 335–340, 1954.
27.
KonzettH.RothlinE.: The effect of narcotine on the cough reflex and on the bronchial muscles, Experientia10: 472–473, 1954.
TonerJ.J.MackoE.: Pharmacology studies on bis-[1-carbo-β-diethylaminoethoxy)-1-phenylcyclo-pentane] - ethane disulfonate, J. Pharmacol. Exp. Ther.106:246–251, 1952.
30.
ChakravartyN.K.MatallanaA.JensenR.BorisonH.L.: Central effects of antitussive drugs on cough and respiration, J. Pharmacol. Exp. Ther.117: 127–135, 1956.
31.
MatallanaA.BorisonH.L.: Antitussive agents and centrally-induced cough, Fed. Proc.14: 367–368, 1955.
32.
ErnstA.M.: Action of narcotics on the ciliated epithelium of the trachea and bronchi, Arch. Int. Pharmacodyn. Ther.58: 208–212, 1938.
33.
ErnstA.M.: Pharmakologische Untersuchungen und Wertbestimmung von hustenstillenden Mitteln, Arch. Int. Pharmacodyn. Ther.58: 363–369, 1938.
van DongenK.: The effect of narcotine, ticarda and Romilar on coughs and on the movements of the cilia in the air passages, Acta Physiol. Pharmacol. Neerl.4: 500–507, 1956.
36.
RosiereCEWinderC.V.WaxJ.: Ammonia cough elicited through a tracheal side tube in unanesthetized dogs; comparative antitussive bioassay of four morphine derivatives and methadone in terms of ammonia thresholds, J. Pharmacol. Exp. Ther.116: 296–316, 1956.
37.
WinterC.A.FlatakerL.: Antitussive action of d-isomethadone and d-methadone in dogs, Proc. Soc. Exp. Biol. Med.81: 463–465, 1952.
38.
ChenJ.Y.P.BillerH.F.MontgomeryE.G.: Pharmacologic studies on a new antitussive, alpha-(dimethylaminoethyl)-ortho-chlorobenzhydrol hydrochloride (SL-501, Bayer B-186), J. Pharmacol. Exp. Ther.128: 384–391, 1960.
39.
GrossA.: Etude experimentale, chez le chien chloralose, de l'action antitussive de la codeine, au moyen du reflexe pleuro-tussigene et de la toux iobelinique, C. R. Soc. Biol. (Paris)151: 704–707, 1957.
40.
KaseY.: The coughing dog: An improved method for the evaluation of an antitussive, Pharm. Bull. (Japan)2: 298–299, 1954.
41.
KaseY.: Pharmacological studies on cough reflex, Part 3. “Coughing dog” and its application, Jap. J. Pharmacol.4: 130–135, 1955.
42.
TedeschiR.E.TedeschiD.H.HitchensJ.T.CookL.MattisP.A.FellowsE.J.: A new antitussive method involving mechanical stimulation in unanesthetized dogs, J. Pharmacol. Exp. Ther.126: 338–344, 1959.
43.
SchroederW.: Die Verwendung des Vagusschlingenhundes fuer die Wertbestimmmung hustenstillender Substanzen, Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol.212: 433–439, 1951.
44.
BobbJ.R.R.EllisS.: Production of cough and its suppression in the unanesthetized dog, Am. J. Physiol.167: 768–769, 1951.
45.
StefkoP.L.BensonW.M.: A method for the evaluation of antitussive agents in the unanesthetized dog, J. Pharmacol. Exp. Ther.108: 217–223, 1953.
BernardM.: Technique de toux experimentale chez le chien par excitation faradique de la pleure viscerale, C.R. Soc. Biol. (Paris)., 150: 1936–1940, 1956.
48.
GrossA.LebonP.RambertR.: Technique de toux experimentale chez le chien par excitation faradique, sous bronchoscopie, de l'eperon tracheal, C. R. Soc. Biol. (Paris), 152: 495–497, 1958.
49.
MansiW.SchofieldP.B.StewartS.J.TownsonR.S.: Contagious rhinitis in dogs, Vet. Rec.77: 940–941, 1965.
50.
PalecekF.MikulaskovaJ.: The pharmacology of pholcodine, Cesk. Farm.12: 89–94, 1963.
51.
WiedemijerJ.C.: A screening method for antitussive compounds, Acta Physiol. Pharmacol. Neerl.9: 501–508, 1960.
52.
ReichleC.FriebelH.: Zur Hemmung des Hustenreflexes durch zentral angreifende Arzneimmittel, Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol.226: 558–562, 1955.
53.
BucherK.,: Antitussive drugs, pp. 175–200. In: RootW.S.HofmannF.G., eds., Physiological Pharmacology, Vol. 2. Academic Press, New York, 1965.
54.
DrummondR.A.: A fishy monitor — or — Gesundheit under water, Ind. Res.16:33, August, 1974.
55.
NicolisF.B.: Evaluation of antitussive agents, pp. 231–265. In: International encyclopedia of pharmacology and therapeutics, sect. 26, Vol. 1. Pergamon Press, London.
56.
TiffeneauR.: The acetylcholine cough test, Dis. Chest, 31: 404–422, 1957.
57.
HaslreiterE.: The acetylcholine cough test as a means of evaluation of a new antitussive, Arzneim. Forsch.9: 769–773, 1959.
58.
PrimeF.J.: The assessment of antitussive drugs in man, Br. Med. J.1: 1149–1151, 1961.
59.
SarvanB.: On the protective effect of anew type of antitussive in the acetylcholine cough test, Med. Klin.57: 1142–1144, 1962.
60.
SeveliusH.HoffmannR.C.BrillM.D.ColmoreJ.P.: Cis-paracoumaric acid in the treatment of pulmonary emphysema and chronic bronchitis, J. New Drugs5: 102–108, 1965.
61.
TrendelenburgU.: The action of a few cough remedies on the cough threshold and respiration, Acta Physiol. Scand.21: 174–186, 1950.
62.
HoeglundN.J.MichaelssonM.: A method for determing the cough threshold with some preliminary experiments on the effect of codeine, Acta Physiol. Scand.21: 168–173, 1950.
63.
BickermanH.A.BarachA.L.: The experimental production of cough in human subjects induced by citric acid aerosols; preliminary studies on the evaluation of antitussive agents, Am. J. Med. Sci.228: 156–163, 1954.
64.
BickermanH.A.CohenB.M.GermanE.: The cough response of normal human subjects stimulated experimentally by citric acid aerosol; alterations produced by antitussive agents, Am. J. Med. Sci.232: 57–65, 1956.
65.
MorrisD.J.ShaneS.J.: Human bioassay of a new antitussive agent, Can. Med. Assoc. J.83: 1093–1095, 1960.
66.
HoffG.ChristensenJ.A.: An important factor in judging experimental cough response [pharmacologic method], Fed. Proc.22: 542, 1963.
67.
CalesnickB.AlexanderE.: Cough threshold as an index of antitussive activity, Fed. Proc.22: 542, 1963.
68.
CalesnickB.ChristensenJ.A.: Latency of cough response as a measure of antitussive agents, Clin. Pharmacol. Ther.8: 374–380, 1967.
69.
SilsonJ.E.: A new method for evaluating antitussive medications using the citric acid challenge technique, J. New Drugs4: 229, 1964.
70.
HillisB.R.: The assessment of cough-suppressing drugs, Lancet1: 1230–1235, 1952.
71.
NadelJ.A.SalemH.TamplinB.TokiwaY.: Mechanism of bronchoconstriction during inhalation of sulfur dioxide, J. Appl. Physiol.20: 164–167, 1965.
72.
EckenhoffJ.E.ComroeJ.H.Jr.: Blocking action of tetraethylammonium on lobelin-induced thoracic pain, Proc. Soc. Exp. Biol. Med.76: 725–726, 1951.
73.
HillisB.R.KellyJ.C.C.: Effect of hexamethonium iodide on lobeline-stimulated coughing, Glasg. Med. J.32: 72–76, 1951.
74.
KonarN.R.DasguptaS.: A chemical method for exciting cough reflex in human beings and its use in assessing the effectiveness of cough sedatives, J. Indian Med. Assoc.32: 189–193, 1959.
75.
BarachA.L.BeckG.J.BickermanH.A.SeanorH.E.: Physical methods simulating mechanisms of the human cough, J. Appl. Physiol.5: 85–91, 1952.
76.
BeckG.J.BickermanH.A.MarderM.J.: Advances in inhalational therapy, Gen. Pract. Clin.10: 51–60, 1954.
77.
DonH.F.RobsonJ.G.: Effect of mechanical stimulation of the lower airway on respiratory mechanics in apneic anesthetized man, Anesthesiology27: 284–287, 1966.
78.
SteinhausJ.E.GaskinL.: A study of intravenous lidocaine as a suppressant of cough reflex, Anesthesiology24: 285–290, 1963.
79.
LoudonR.G.BrownL.C.HurstS.K.: Cough frequency in a group of males, Arch. Environ. Health11: 372–374, 1965.
80.
PlumbC.S.: Clinical evaluation of an expectorant in an industrial facility, Clin. Med.69: 2014–2018, 1962.
81.
SnyderA.J.: How reliably can industrial dispensaries rate the same drug given in disguised forms, Ind. Med. Surg.33: 661–662, 1964.
CassL.J.FrederikW.S.AndoscaJ.B.: Quantitative comparison of dextromethorphan hydrobromide and codeine, Am. J. Med. Sci.227: 291–296, 1954.
84.
RalphN.: Evaluation of a new cough suppressant, Am. J. Med. Sci.227: 297–303, 1954.
85.
SnellE.S.ArmitageP.: Clinical comparison of diamorphine and pholcodine as cough suppressants by a new method of sequential analysis, Lancet272: 860–862, 1957.
86.
GruberC.M.Jr.CarterG.H.ChernishS.M.EpsteinI.L.KillingerR.R.LargaespadaM.PriebeF.RafalskiT.A.SparkmanD.R.: Evaluation of an antitussive drug, J. Indiana Med. Assoc.54: 1643–1646, 1961.
87.
WoolfC.R.RosenbergA.: The cough suppressant effect of heroin and codeine: A controlled clinical study, Can. Med. Assoc. J.86: 810–812, 1962.
88.
WoolfC.R.RosenbergA.: The objective assessment of cough suppressants under clinical conditions using a tape recording system, Am. Rev. Respir. Dis86: 115, 1962.
89.
WoolfC.R.RosenbergA.: Objective assessment of cough suppressants under clinical conditions using a tape recorder system, Thorax19: 125–130, 1964.
90.
NicolisF.B.PasquarielloG.: Controlled clinical trials of antitussive agents; an experimental evaluation of different methods, J. Pharmacol. Exp. Ther.136: 183–189, 1962.
91.
ChernishS.M.LewisG.KraftB.HowellJ.: Clinical evaluation of a new antitussive preparation, Ann. Allergy21: 677–682, 1963.
92.
KaplanH.SherwoodH.EpsteinJ.: Clinical impression and subsequent double blind study of an antitussive preparation, Ann. Allergy23: 111–114, 1965.
93.
SeveliusH.ColmoreJ.P.: Objective assessment of antitussive agents in patients with chronic cough, J. New Drugs5: 262, 1965.
94.
SeveliusH.ColmoreJ.P.: Objective assessment of antitussive agents in patients with chronic coughJ. New Drugs6: 216–223, 1966.
95.
Food & Drug Administration: Prescription drugs indicated for cough and allergy; hearing on interim guidelines for formulation and labeling, Fed. Regist.38: 12769–71, May 15, 1973.
96.
BurrowsB.NidenA.H.BarclayW.R.KasikJ.E.: Chronic obstructive lung disease I. Clinical and physiologic findings in 175 patients and their relationship to age and sex, Am. Rev. Respir. Dis.91: 521–540, 1965.
97.
GaenslerE.A.LindgrenI.: Chronic Bronchitis as an etiologic factor in obstructive emphysema, Am. Rev. Respir. Dis.80: 185–193, 1959.
98.
TalamoR.C.BlennerhassettJ.B.AustenK.F.: Familial emphysema and alpha1-antitrypsin deficiency, N. Engl. J. Med.275: 1301–1304, 1966.
99.
WattsR.E.BennettD.J.HortonD.A.WrightJ.S.: Spontaneous pneumothorax; a rational approach to treatment, Med. J. Aust.1: 538–539, 1970.
100.
GruhzitC.C.: Chemoreflex activity of dextromethorphan (Romilar), dextrorphan, codeine and morphine in the cat and the dog, J. Pharmacol. Exp. Ther.120: 399–407, 1957.
101.
KalishJ.: Modern cough mixtures, Drug Cosmet. Ind.92: 696–698, 1963.
102.
SokoloffM.J.: Mechanisms and management of cough, Med. Clin. North Am.45: 1437–1442, 1961.
103.
OrnstonD.G.: A contribution to cough control, Med. Times75: 370–400, 1947.
104.
ChristopheK.: Experiences in relief of cough by use of an orally inhaled aliphatic amine, Med. Rec.161: 417–418, 1948.
105.
SilcoxL.E.: A new drug for the control of cough, Arch. Otolaryngol.47: 822–824, 1948.